[Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure].
Latini
R
R
Istituto di Ricerche Farmacologiche Mario Negri, Milano.
D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D015444:Exercise; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D017706:Lisinopril / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013841:Thiazepines / Q000627:therapeutic use*
D002316:Cardiotonic Agents; D002317:Cardiovascular Agents; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat; D017706:Lisinopril
Confronto tra un inibitore della vasopeptidasi neutra e lisinopril sulla tolleranza allo sforzo e morbidità in pazienti con scompenso cardiaco.